Rapid Sequence Intubation 🔥🔥🔥

Rapid Sequence Intubation (RSI), also referred to as Drug-Assisted Intubation (DAI), is a critical procedure utilized to safely secure the airway in children with impending respiratory failure or profound hypoxemia.
A Glasgow Coma Scale (GCS) score of less than 8, often seen in conditions like status epilepticus or traumatic brain injury, is a primary indication for immediate intubation to protect the airway.
RSI is also indicated for refractory hypoxemia (inability of supplemental oxygen to raise PaO2 to 55-60 mmHg), severe hypercarbia (PaCO2 > 45 mmHg), apnea, or the loss of protective airway reflexes.
Cardiovascular signs of profound hypoxia, including marked tachycardia, severe bradycardia, or hypotension, necessitate urgent airway control.

Preoxygenation with 100% oxygen is a mandatory initial step to maximize oxygen reserves, and the clinician must anticipate and prepare for potential procedure-induced hypotension.
The application of cricoid pressure can be considered in unconscious children to minimize the risk of gastric aspiration; however, it must be promptly discontinued if it impedes bag-mask ventilation or interferes with the ease of intubation.
The intubation procedure should be gentle and strictly controlled; prolonged or multiple intubation attempts must be avoided to prevent secondary physiological derangements.
Atropine is not routinely recommended prior to intubation but should be used as a premedication when the risk of bradycardia is elevated, such as in young infants, near-drowning patients, or when succinylcholine is administered.
In patients with suspected raised intracranial pressure (ICP), a cerebroprotective DAI approach is preferred, utilizing pharmacological adjuncts like intravenous lidocaine to blunt the reflex increase in ICP triggered by airway manipulation.

RSI must always precede the neuromuscular blockade with an appropriate sedative or anesthetic agent to provide amnesia, reduce anxiety, and blunt catecholamine release.
Ketamine is the induction agent of choice in children presenting with acute severe asthma due to its potent bronchodilatory effects and minimal respiratory depression.
For hemodynamically stable children, particularly those with raised ICP, induction can be achieved using midazolam (0.2-0.3 mg/kg IV) or etomidate (0.1-0.3 mg/kg IV), often combined with fentanyl (5-10 mcg/kg IV) for analgesia.
Midazolam should be avoided in hemodynamically unstable patients to prevent precipitous drops in blood pressure.
In cases of cardiogenic shock, sedatives can dangerously blunt endogenous catecholamines and reduce right ventricular preload; therefore, pre-medication with small boluses of epinephrine may be required to counterbalance these hemodynamic effects.

Following the administration of the sedative, a rapid-acting muscle relaxant is given to achieve complete vocal cord paralysis and optimize intubating conditions.
Short-acting non-depolarizing neuromuscular blocking agents are frequently recommended for this purpose.
Standard non-depolarizing options include vecuronium (0.1 mg/kg IV), atracurium (0.5 mg/kg IV), or rocuronium (0.6-1.2 mg/kg IV).
Succinylcholine, a depolarizing agent, may also be utilized to facilitate rapid intubation, provided that atropine premedication is considered to mitigate the risk of severe bradycardia.